|
Oct 9
|
Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30
|
|
Jun 17
|
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
|
|
Nov 28
|
Bausch + Lomb CEO Brent Saunders Pays $35.35 Million for Cher’s Former Miami Beach Home
|
|
Sep 20
|
Bausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winners
|
|
Sep 19
|
Is the Options Market Predicting a Spike in Bausch + Lomb (BLCO) Stock?
|
|
Sep 18
|
Novartis' (NVS) Shareholders Approve Sandoz Separation
|
|
Sep 6
|
Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA®
|
|
Sep 6
|
Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting
|
|
Jul 11
|
Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2
|
|
Jul 6
|
Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops
|
|
Apr 26
|
Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting
|
|
Apr 25
|
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
|
|
Apr 24
|
Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System
|